Computational analysis of structural and functional evaluation of the deleterious missense variants in the human CTLA4 gene

References

• Abbas, G. (2011). CTLA4 gene variants in autoimmunity and cancer: A comparative review. Iranian Journal of Immunology : IJI, 8(3), 127–149. https://pubmed.ncbi.nlm.nih.gov/21931200
   Web of Science ®Google Scholar
• Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/10.1016/j.softx.2015.06.001
   Google Scholar
• Abraham, M. J., Van der Spoel, D., Lindahl, E., & Hess, B. (2019). GROMACS user manual version 2019.3. http://www.gromacs.org
   Google Scholar
• Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7(4), 248–249. https://doi.org/10.1038/nmeth0410-248
   PubMed Web of Science ®Google Scholar
• Ashkenazy, H., Abadi, S., Martz, E., Chay, O., Mayrose, I., Pupko, T., & Ben-Tal, N. (2016). ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Research, 44(W1), W344–350. https://doi.org/10.1093/nar/gkw408
   PubMed Web of Science ®Google Scholar
• Balcão, V. M., & Vila, M. M. D. C. (2015). Structural and functional stabilization of protein entities: State-of-the-art. Advanced Drug Delivery Reviews, 93, 25–41. https://doi.org/10.1016/j.addr.2014.10.005
   PubMed Web of Science ®Google Scholar
• Bansal, A., Tasnim, S., Gupta, M. D., Mp, G., Batra, V., Kohli, S., Tyagi, S., & Pasha, M. A. Q. (2021). Susceptibility of CTLA-4 -1661A/G polymorphism towards severity of rheumatic heart disease. Indian Heart Journal, 73(4), 511–515. https://doi.org/10.1016/j.ihj.2021.05.002
   PubMedGoogle Scholar
• Belkaid, Y., & Rouse, B. T. (2005). Natural regulatory T cells in infectious disease. Nature Immunology, 6(4), 353–360. https://doi.org/10.1038/ni1181
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J., P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Bouqbis, L., Izaabel, H., Akhayat, O., Pérez-Lezaun, A., Calafell, F., Bertranpetit, J., & Comas, D. (2003). Association of the CTLA4 promoter region (−1661G allele) with type 1 diabetes in the South Moroccan population. Genes and Immunity, 4(2), 132–137. https://doi.org/10.1038/sj.gene.6363933
   PubMed Web of Science ®Google Scholar
• Bowie, J. U., Lüthy, R., & Eisenberg, D. (1991). A method to identify protein sequences that fold into a known three-dimensional structure. Science (New York, N.Y.), 253(5016), 164–170. https://doi.org/10.1126/science.1853201
   PubMed Web of Science ®Google Scholar
• Bromberg, Y., & Rost, B. (2007). SNAP: Predict effect of non-synonymous polymorphisms on function. Nucleic Acids Research, 35(11), 3823–3835. https://doi.org/10.1093/nar/gkm238
   PubMed Web of Science ®Google Scholar
• Brunet, J. F., Denizot, F., Luciani, M. F., Roux-Dosseto, M., Suzan, M., Mattei, M. G., & Golstein, P. (1987). A new member of the immunoglobulin superfamily—CTLA-4. Nature, 328(6127), 267–270. https://doi.org/10.1038/328267a0
   PubMed Web of Science ®Google Scholar
• Buckner, J. H. (2010). Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nature Reviews. Immunology, 10(12), 849–859. https://doi.org/10.1038/nri2889
   PubMed Web of Science ®Google Scholar
• Calabrese, R., Capriotti, E., Fariselli, P., Martelli, P. L., & Casadio, R. (2009). Functional annotations improve the predictive score of human disease-related mutations in proteins. Human Mutation, 30(8), 1237–1244. https://doi.org/10.1002/humu.21047
   PubMed Web of Science ®Google Scholar
• Capriotti, E., & Altman, R. B. (2011). Improving the prediction of disease-related variants using protein three-dimensional structure. BMC Bioinformatics, 12(Suppl 4), S3. https://doi.org/10.1186/1471-2105-12-S4-S3
   PubMedGoogle Scholar
• Capriotti, E., Calabrese, R., & Casadio, R. (2006). Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics (Oxford, England), 22(22), 2729–2734. https://doi.org/10.1093/bioinformatics/btl423
   PubMed Web of Science ®Google Scholar
• Capriotti, E., Fariselli, P., Calabrese, R., & Casadio, R. (2005). Predicting protein stability changes from sequences using support vector machines. Bioinformatics (Oxford, England), 21, ii54–ii58. https://doi.org/10.1093/bioinformatics/bti1109
   Google Scholar
• Çelmeli, F., Türkkahraman, D., Özel, D., Akçurin, S., & Yegin, O. (2013). CTLA-4 (+49A/G) polymorphism and type-1 diabetes in Turkish children. Journal of Clinical Research in Pediatric Endocrinology, 5(1), 40–43. https://doi.org/10.4274/Jcrpe.879
   PubMed Web of Science ®Google Scholar
• Chasman, D., & Adams, R. M. (2001). Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation. Journal of Molecular Biology, 307(2), 683–706. https://doi.org/10.1006/jmbi.2001.4510
   PubMed Web of Science ®Google Scholar
• Chen, C.-W., Lin, J., & Chu, Y.-W. (2013). iStable: Off-the-shelf predictor integration for predicting protein stability changes. BMC Bioinformatics, 14(Suppl 2), S5. https://doi.org/10.1186/1471-2105-14-S2-S5
   Google Scholar
• Chen, C.-W., Lin, M.-H., Liao, C.-C., Chang, H.-P., & Chu, Y.-W. (2020). iStable 2.0: Predicting protein thermal stability changes by integrating various characteristic modules. Computational and Structural Biotechnology Journal, 18, 622–630. https://doi.org/10.1016/j.csbj.2020.02.021
   PubMed Web of Science ®Google Scholar
• Chen, M., Chang, Y., Tang, F., Xie, Q.-H., Li, J., Yang, H., He, X.-X., & Lin, J.-S. (2014). Influence of cytotoxic T lymphocyte-associated antigen 4 polymorphisms on the outcomes of hepatitis B virus infection. Molecular Medicine Reports, 9(2), 645–652. https://doi.org/10.3892/mmr.2013.1825
   PubMed Web of Science ®Google Scholar
• Chen, Y., Lu, H., Zhang, N., Zhu, Z., Wang, S., & Li, M. (2020). PremPS: Predicting the impact of missense mutations on protein stability. PLoS Computational Biology, 16(12), e1008543. https://doi.org/10.1371/journal.pcbi.1008543
   PubMed Web of Science ®Google Scholar
• Cheng, J., Randall, A., & Baldi, P. (2005). Prediction of protein stability changes for single-site mutations using support vector machines. Proteins: Structure, Function, and Bioinformatics, 62(4), 1125–1132. https://doi.org/10.1002/prot.20810
   Web of Science ®Google Scholar
• Chistiakov, D. A., & Turakulov, R. I. (2003). CTLA-4 and its role in autoimmune thyroid disease. Journal of Molecular Endocrinology, 31(1), 21–36. https://doi.org/10.1677/jme.0.0310021
   PubMed Web of Science ®Google Scholar
• Choi, Y., & Chan, A. P. (2015). PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics, 31(16), 2745–2747. https://doi.org/10.1093/bioinformatics/btv195
   PubMed Web of Science ®Google Scholar
• Choi, Y., Sims, G. E., Murphy, S., Miller, J. R., & Chan, A. P. (2012). Predicting the functional effect of amino acid substitutions and indels. PloS One, 7(10), e46688. https://doi.org/10.1371/journal.pone.0046688
   PubMed Web of Science ®Google Scholar
• Collins, F. S., Brooks, L. D., & Chakravarti, A. (1998). A DNA polymorphism discovery resource for research on human genetic variation. Genome Research, 8(12), 1229–1231. https://doi.org/10.1101/gr.8.12.1229
   PubMed Web of Science ®Google Scholar
• Colovos, C., & Yeates, T. O. (1993). Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Science : A Publication of the Protein Society, 2(9), 1511–1519. https://doi.org/10.1002/pro.5560020916
   PubMed Web of Science ®Google Scholar
• Dariavach, P., Mattéi, M. G., Golstein, P., & Lefranc, M. P. (1988). Human Ig superfamily CTLA-4 gene: Chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. European Journal of Immunology, 18(12), 1901–1905. https://doi.org/10.1002/eji.1830181206
   PubMed Web of Science ®Google Scholar
• Dieu-Nosjean, M.-C., & Caux, C. (2019). La biologie des cibles PD-1 et CTLA-4 et la question des biomarqueurs. médecine/sciences, 35(12), 957–965. https://doi.org/10.1051/medsci/2019192
   Google Scholar
• Ebrahim, E., Teklu, T., Tajebe, F., Wondmagegn, T., Akelew, Y., & Fiseha, M. (2022). Association of cytotoxic T-lymphocyte antigen-4 gene polymorphism with type 1 diabetes mellitus: In silico analysis of biological features of CTLA-4 protein on Ethiopian population. Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy, 15, 2733–2751. https://doi.org/10.2147/DMSO.S375023
   PubMed Web of Science ®Google Scholar
• Friedline, R. H., Brown, D. S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., Appleby, M., Der, S. D., Kang, J., & Chambers, C. A. (2009). CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. The Journal of Experimental Medicine, 206(2), 421–434. https://doi.org/10.1084/jem.20081811
   PubMed Web of Science ®Google Scholar
• Glaser, F., Pupko, T., Paz, I., Bell, R. E., Bechor-Shental, D., Martz, E., & Ben-Tal, N. (2003). ConSurf: Identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics (Oxford, England), 19(1), 163–164. https://doi.org/10.1093/bioinformatics/19.1.163
   Google Scholar
• Glaser, F., Rosenberg, Y., Kessel, A., Pupko, T., & Ben-Tal, N. (2005). The ConSurf-HSSP database: The mapping of evolutionary conservation among homologs onto PDB structures. Proteins, 58(3), 610–617. https://doi.org/10.1002/prot.20305
   PubMed Web of Science ®Google Scholar
• Goske, M., Ramachander, V. R. V., Komaravalli, P. L., Rahman, P. F., Rao, C., & Jahan, P. (2017). CTLA-4 genetic variants (rs11571317 and rs3087243): Role in susceptibility and progression of breast cancer. World Journal of Oncology, 8(5), 162–170. https://doi.org/10.4021/wjon.v8i5.1046
   PubMedGoogle Scholar
• Harper, K., Balzano, C., Rouvier, E., Mattéi, M. G., Luciani, M. F., & Golstein, P. (1991). CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. Journal of Immunology (Baltimore, Md. : 1950), 147(3), 1037–1044.
   PubMed Web of Science ®Google Scholar
• Hasan, G. A., & Altamemi, I. A. (2022). CTLA-4 polymorphism along with proinflammatory cytokines in autoimmune thyroiditis disease. Wiadomości Lekarskie, 75(3), 577–583. https://doi.org/10.36740/WLek202203103
   PubMedGoogle Scholar
• Hosseini, A., Gharibi, T., Marofi, F., Babaloo, Z., & Baradaran, B. (2020). CTLA-4: From mechanism to autoimmune therapy. International Immunopharmacology, 80, 106221. https://doi.org/10.1016/j.intimp.2020.106221
   PubMed Web of Science ®Google Scholar
• Hu, S., Pu, D., Xia, X., Guo, B., & Zhang, C. (2020). CTLA-4 rs5742909 polymorphism and cervical cancer risk: A meta-analysis. Medicine, 99(11), e19433. https://doi.org/10.1097/MD.0000000000019433
   PubMed Web of Science ®Google Scholar
• Huang, F., He, Q., Jiao, X., Zhang, H., & Chang, Q. (2020). Meta-analysis of CTLA-4 + 49 gene polymorphism and susceptibility to graves’ disease. Critical Reviews in Eukaryotic Gene Expression, 30(5), 377–390. https://doi.org/10.1615/CritRevEukaryotGeneExpr.2020034872
   PubMed Web of Science ®Google Scholar
• Huang, J., & MacKerell, A. D., Jr. (2013). CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. https://doi.org/10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Jaiswal, P. K., Singh, V., & Mittal, R. D. (2014). Cytotoxic T lymphocyte antigen 4 (CTLA4) gene polymorphism with bladder cancer risk in North Indian population. Molecular Biology Reports, 41(2), 799–807. https://doi.org/10.1007/s11033-013-2919-2
   PubMed Web of Science ®Google Scholar
• June, C. H., Bluestone, J. A., Nadler, L. M., & Thompson, C. B. (1994). The B7 and CD28 receptor families. Immunology Today, 15(7), 321–331. https://doi.org/10.1016/0167-5699(94)90080-9
   PubMedGoogle Scholar
• June, C. H., Ledbetter, J. A., Linsley, P. S., & Thompson, C. B. (1990). Role of the CD28 receptor in T-cell activation. Immunology Today, 11(6), 211–216. https://doi.org/10.1016/0167-5699(90)90085-n
   PubMedGoogle Scholar
• Karabon, L., Kosmaczewska, A., Bilinska, M., Pawlak, E., Ciszak, L., Jedynak, A., Jonkisz, A., Noga, L., Pokryszko-Dragan, A., Koszewicz, M., & Frydecka, I. (2009). The CTLA-4 gene polymorphisms are associated with CTLA-4 protein expression levels in multiple sclerosis patients and with susceptibility to disease. Immunology, 128(1 Suppl), e787–e796. https://doi.org/10.1111/j.1365-2567.2009.03083.x
   PubMed Web of Science ®Google Scholar
• Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996). CTLA-4: A negative regulator of autoimmune disease. The Journal of Experimental Medicine, 184(2), 783–788. https://doi.org/10.1084/jem.184.2.783
   PubMed Web of Science ®Google Scholar
• Katta, V., Chait, B. T., & Carr, S. (1991). Conformational changes in proteins probed by hydrogen-exchange electrospray-ionization mass spectrometry. Rapid Communications in Mass Spectrometry : RCM, 5(4), 214–217. https://doi.org/10.1002/rcm.1290050415
   PubMed Web of Science ®Google Scholar
• Kaykhaei, M., Moghadam, H., Dabiri, S., Salimi, S., Jahantigh, D., Tamandani, D. M. K., Rasouli, A., & Narooie-Nejad, M. (2020). Association of CTLA4 (rs4553808) and PTPN22 (rs2476601) gene polymorphisms with Hashimoto’s thyroiditis disease: A case-control study and an In-silico analysis. Meta Gene, 24, 100693. https://doi.org/10.1016/j.mgene.2020.100693
   Web of Science ®Google Scholar
• Kearney, E. R., Walunas, T. L., Karr, R. W., Morton, P. A., Loh, D. Y., Bluestone, J. A., & Jenkins, M. K. (1995). Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4. The Journal of Immunology, 155(3), 1032–1036. https://doi.org/10.4049/jimmunol.155.3.1032
   PubMed Web of Science ®Google Scholar
• Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007). Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nature Immunology, 8(2), 191–197. https://doi.org/10.1038/ni1428
   PubMed Web of Science ®Google Scholar
• Krummel, M. F., & Allison, J. P. (1995). CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. Journal of Experimental Medicine, 182(2), 459–465. https://doi.org/10.1084/jem.182.2.459
   PubMed Web of Science ®Google Scholar
• Krummel, M. F., Sullivan, T. J., & Allison, J. P. (1996). Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. International Immunology, 8(4), 519–523. https://doi.org/10.1093/intimm/8.4.519
   PubMed Web of Science ®Google Scholar
• Kucukkal, T. G., Petukh, M., Li, L., & Alexov, E. (2015). Structural and physico-chemical effects of disease and non-disease nsSNPs on proteins. Current Opinion in Structural Biology, 32, 18–24. https://doi.org/10.1016/j.sbi.2015.01.003
   PubMed Web of Science ®Google Scholar
• Lander, E. S. (1996). The new genomics: Global views of biology. Science (New York, N.Y.), 274(5287), 536–539. https://doi.org/10.1126/science.274.5287.536
   PubMed Web of Science ®Google Scholar
• Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., & Bluestone, J. A. (1998). Molecular basis of T cell inactivation by CTLA-4. Science (New York, N.Y.), 282(5397), 2263–2266. https://doi.org/10.1126/science.282.5397.2263
   PubMed Web of Science ®Google Scholar
• Leung, H. T., Bradshaw, J., Cleaveland, J. S., & Linsley, P. S. (1995). Cytotoxic T lymphocyte-associated molecule-4, a high-avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail. The Journal of Biological Chemistry, 270(42), 25107–25114. https://doi.org/10.1074/jbc.270.42.25107
   PubMed Web of Science ®Google Scholar
• Li, B., Krishnan, V., Mort, M., Xin, F., Kamati, K., Cooper, D., Mooney, S., & Radivojac, P. (2009). Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics (Oxford, England), 25(21), 2744–2750. https://doi.org/10.1093/bioinformatics/btp528
   PubMed Web of Science ®Google Scholar
• Lindsten, T., Lee, K. P., Harris, E. S., Petryniak, B., Craighead, N., Reynolds, P. J., Lombard, D. B., Freeman, G. J., Nadler, L. M., & Gray, G. S. (1993). Characterization of CTLA-4 structure and expression on human T cells. The Journal of Immunology, 151(7), 3489–3499. https://doi.org/10.4049/jimmunol.151.7.3489
   PubMed Web of Science ®Google Scholar
• Linsley, P. S., Greene, J. L., Brady, W., Bajorath, J., Ledbetter, J. A., & Peach, R. (1994). Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity, 1(9), 793–801. https://doi.org/10.1016/s1074-7613(94)80021-9
   PubMed Web of Science ®Google Scholar
• Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002). CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the Nonredundant Function of IL-2. Immunity, 17(2), 167–178. https://doi.org/10.1016/s1074-7613(02)00367-9
   Google Scholar
• Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC/E water models at 298 K. The Journal of Physical Chemistry A, 105(43), 9954–9960. https://doi.org/10.1021/jp003020w
   Web of Science ®Google Scholar
• Mayrose, I., Graur, D., Ben-Tal, N., & Pupko, T. (2004). Comparison of site-specific rate-inference methods for protein sequences: Empirical Bayesian methods are superior. Molecular Biology and Evolution, 21(9), 1781–1791. https://doi.org/10.1093/molbev/msh194
   PubMed Web of Science ®Google Scholar
• Metzler, W. J., Bajorath, J., Fenderson, W., Shaw, S. Y., Constantine, K. L., Naemura, J., Leytze, G., Peach, R. J., Lavoie, T. B., Mueller, L., & Linsley, P. S. (1997). Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28. Nature Structural Biology, 4(7), 527–531. https://doi.org/10.1038/nsb0797-527
   PubMedGoogle Scholar
• Mi, H., Muruganujan, A., & Thomas, P. D. (2013). PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Research, 41(Database issue), D377–386. https://doi.org/10.1093/nar/gks1118
   PubMedGoogle Scholar
• Ng, P. C., & Henikoff, S. (2001). Predicting Deleterious Amino Acid Substitutions. Genome Research, 11(5), 863–874. https://doi.org/10.1101/gr.176601
   PubMed Web of Science ®Google Scholar
• Ng, P. C., & Henikoff, S. (2003). SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research, 31(13), 3812–3814. https://doi.org/10.1093/nar/gkg509
   PubMed Web of Science ®Google Scholar
• Nisticò, L., Buzzetti, R., Pritchard, L. E., Van der Auwera, B., Giovannini, C., Bosi, E., Larrad, M. T., Rios, M. S., Chow, C. C., Cockram, C. S., Jacobs, K., Mijovic, C., Bain, S. C., Barnett, A. H., Vandewalle, C. L., Schuit, F., Gorus, F. K., Tosi, R., Pozzilli, P., & Todd, J. A. (1996). The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Human Molecular Genetics, 5(7), 1075–1080. https://doi.org/10.1093/hmg/5.7.1075
   PubMed Web of Science ®Google Scholar
• Olechnovič, K., & Venclovas, Č. (2017). VoroMQA: Assessment of protein structure quality using interatomic contact areas. Proteins, 85(6), 1131–1145. https://doi.org/10.1002/prot.25278
   PubMed Web of Science ®Google Scholar
• Pace, C. N., Fu, H., Fryar, K. L., Landua, J., Trevino, S. R., Schell, D., Thurlkill, R. L., Imura, S., Scholtz, J. M., Gajiwala, K., Sevcik, J., Urbanikova, L., Myers, J. K., Takano, K., Hebert, E. J., Shirley, B. A., & Grimsley, G. R. (2014). Contribution of hydrogen bonds to protein stability. Protein Science : A Publication of the Protein Society, 23(5), 652–661. https://doi.org/10.1002/pro.2449
   PubMed Web of Science ®Google Scholar
• Pardoll, D. M. (2012). The blockade of immune checkpoints in cancer immunotherapy. Nature Reviews. Cancer, 12(4), 252–264. https://doi.org/10.1038/nrc3239
   PubMed Web of Science ®Google Scholar
• Pejaver, V., Urresti, J., Lugo-Martinez, J., Pagel, K. A., Lin, G. N., Nam, H.-J., Mort, M., Cooper, D. N., Sebat, J., Iakoucheva, L. M., Mooney, S. D., & Radivojac, P. (2020). Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nature Communications, 11(1), 1–13. https://doi.org/10.1038/s41467-020-19669-x
   PubMed Web of Science ®Google Scholar
• Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera—A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084
   PubMed Web of Science ®Google Scholar
• Petukh, M., Kucukkal, T. G., & Alexov, E. (2015). On human disease-causing amino acid variants: Statistical study of sequence and structural patterns. Human Mutation, 36(5), 524–534. https://doi.org/10.1002/humu.22770
   PubMed Web of Science ®Google Scholar
• Quezada, S. A., Peggs, K. S., Curran, M. A., & Allison, J. P. (2006). CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. The Journal of Clinical Investigation, 116(7), 1935–1945. https://doi.org/10.1172/JCI27745
   PubMed Web of Science ®Google Scholar
• Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., Hou, T. Z., Futter, C. E., Anderson, G., Walker, L. S. K., & Sansom, D. M. (2011). Trans-endocytosis of CD80 and CD86: A molecular basis for the cell extrinsic function of CTLA-4. Science (New York, N.Y.), 332(6029), 600–603. https://doi.org/10.1126/science.1202947
   PubMed Web of Science ®Google Scholar
• Ramagopal, U. A., Liu, W., Garrett-Thomson, S. C., Bonanno, J. B., Yan, Q., Srinivasan, M., Wong, S. C., Bell, A., Mankikar, S., Rangan, V. S., Deshpande, S., Korman, A. J., & Almo, S. C. (2017). Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab. Proceedings of the National Academy of Sciences of the United States of America, 114(21), E4223–E4232. https://doi.org/10.1073/pnas.1617941114
   PubMed Web of Science ®Google Scholar
• Ramensky, V., Bork, P., & Sunyaev, S. (2002). Human non-synonymous SNPs: Server and survey. Nucleic Acids Research, 30(17), 3894–3900. https://doi.org/10.1093/nar/gkf493
   PubMed Web of Science ®Google Scholar
• Read, S., Malmström, V., & Powrie, F. (2000). Cytotoxic T lymphocyte–associated antigen 4 plays an essential role in the function of Cd25 + Cd4+ regulatory cells that control intestinal inflammation. The Journal of Experimental Medicine, 192(2), 295–302. https://doi.org/10.1084/jem.192.2.295
   PubMed Web of Science ®Google Scholar
• Reva, B., Antipin, Y., & Sander, C. (2007). Determinants of protein function revealed by combinatorial entropy optimization. Genome Biology, 8(11), R232. https://doi.org/10.1186/gb-2007-8-11-r232
   PubMed Web of Science ®Google Scholar
• Reva, B., Antipin, Y., & Sander, C. (2011). Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Research, 39(17), e118. https://doi.org/10.1093/nar/gkr407
   PubMed Web of Science ®Google Scholar
• Rudd, C. E. (2008). The reverse stop-signal model for CTLA4 function. Nature Reviews. Immunology, 8(2), 153–160. https://doi.org/10.1038/nri2253
   PubMed Web of Science ®Google Scholar
• Schrödinger. (2021). The PyMOL Molecular Graphics System, Version 2.5.2 Schrödinger, LLC.
   Google Scholar
• Schubert, D., Bode, C., Kenefeck, R., Hou, T. Z., Wing, J. B., Kennedy, A., Bulashevska, A., Petersen, B.-S., Schäffer, A. A., Grüning, B. A., Unger, S., Frede, N., Baumann, U., Witte, T., Schmidt, R. E., Dueckers, G., Niehues, T., Seneviratne, S., Kanariou, M., … Grimbacher, B. (2014). Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations. Nature Medicine, 20(12), 1410–1416. https://doi.org/10.1038/nm.3746
   PubMed Web of Science ®Google Scholar
• Seidel, J. A., Otsuka, A., & Kabashima, K. (2018). Anti-PD-1 and anti-CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations. Frontiers in Oncology, 8, 86. https://doi.org/10.3389/fonc.2018.00086
   PubMed Web of Science ®Google Scholar
• Sharpe, A. H., & Freeman, G. J. (2002). The B7-CD28 superfamily. Nature Reviews. Immunology, 2(2), 116–126. https://doi.org/10.1038/nri727
   PubMed Web of Science ®Google Scholar
• Shihab, H. A., Gough, J., Cooper, D. N., Stenson, P. D., Barker, G. L. A., Edwards, K. J., Day, I., N., M., & Gaunt, T. R. (2013). Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Human Mutation, 34(1), 57–65. https://doi.org/10.1002/humu.22225
   PubMed Web of Science ®Google Scholar
• Sippl, M. J. (1993). Recognition of errors in three-dimensional structures of proteins. Proteins: Structure, Function, and Genetics, 17(4), 355–362. https://doi.org/10.1002/prot.340170404
   PubMed Web of Science ®Google Scholar
• Siri, A., Boysson, H. d., & Boursier, G. (2012). Actualité sur les lymphocytes T régulateurs CD4+. médecine/sciences, 28(6-7), 646–647), Article 6–7. ( https://doi.org/10.1051/medsci/2012286019
   Google Scholar
• Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000). Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. The Journal of Experimental Medicine, 192(2), 303–310. https://doi.org/10.1084/jem.192.2.303
   PubMed Web of Science ®Google Scholar
• Tang, H., & Thomas, P. D. (2016). PANTHER-PSEP: Predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics (Oxford, England), 32(14), 2230–2232. https://doi.org/10.1093/bioinformatics/btw222
   PubMed Web of Science ®Google Scholar
• Tanhapour, M., Vaisi-Raygani, A., Khazaei, M., Rahimi, Z., Pourmotabbed, T., Tanhapour, M., Vaisi-Raygani, A., Khazaei, M., Rahimi, Z., & Pourmotabbed, T. (2017). Cytotoxic T-lymphocyte associated antigen-4 (CTLA-4) polymorphism, cancer, and autoimmune diseases. AIMS Medical Science, 4(4), 395–412. https://doi.org/10.3934/medsci.2017.4.395
   Google Scholar
• Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2006). A molecular perspective of CTLA-4 function. Annual Review of Immunology, 24, 65–97. https://doi.org/10.1146/annurev.immunol.24.021605.090535
   PubMed Web of Science ®Google Scholar
• Thio, C. L., Mosbruger, T. L., Kaslow, R. A., Karp, C. L., Strathdee, S. A., Vlahov, D., O'Brien, S. J., Astemborski, J., & Thomas, D. L. (2004). Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. Journal of Virology, 78(20), 11258–11262. https://doi.org/10.1128/JVI.78.20.11258-11262.2004
   PubMed Web of Science ®Google Scholar
• Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity, 3(5), 541–547. https://doi.org/10.1016/1074-7613(95)90125-6
   PubMed Web of Science ®Google Scholar
• Valk, E., Leung, R., Kang, H., Kaneko, K., Rudd, C. E., & Schneider, H. (2006). T cell receptor-interacting molecule acts as a chaperone to modulate surface expression of the CTLA-4 coreceptor. Immunity, 25(5), 807–821. https://doi.org/10.1016/j.immuni.2006.08.024
   PubMed Web of Science ®Google Scholar
• Van Coillie, S., Wiernicki, B., & Xu, J. (2020). Molecular and cellular functions of CTLA-4. Advances in Experimental Medicine and Biology, 1248, 7–32. https://doi.org/10.1007/978-981-15-3266-5_2
   PubMed Web of Science ®Google Scholar
• Walker, L. S. K. (2013). Treg and CTLA-4: Two intertwining pathways to immune tolerance. Journal of Autoimmunity, 45(100), 49–57. https://doi.org/10.1016/j.jaut.2013.06.006
   PubMed Web of Science ®Google Scholar
• Walker, L. S. K., & Sansom, D. M. (2011). The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses. Nature Reviews. Immunology, 11(12), 852–863. https://doi.org/10.1038/nri3108
   PubMed Web of Science ®Google Scholar
• Walunas, T. L., Bakker, C. Y., & Bluestone, J. A. (1996). CTLA-4 ligation blocks CD28-dependent T cell activation. The Journal of Experimental Medicine, 183(6), 2541–2550. https://doi.org/10.1084/jem.183.6.2541
   PubMed Web of Science ®Google Scholar
• Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994). CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1(5), 405–413. https://doi.org/10.1016/1074-7613(94)90071-X
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35, W407–W410. https://doi.org/10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Williams, C. J., Headd, J. J., Moriarty, N. W., Prisant, M. G., Videau, L. L., Deis, L. N., Verma, V., Keedy, D. A., Hintze, B. J., Chen, V. B., Jain, S., Lewis, S. M., Arendall, W. B., Snoeyink, J., Adams, P. D., Lovell, S. C., Richardson, J. S., & Richardson, D. C. (2018). MolProbity: More and better reference data for improved all-atom structure validation. Protein Science : A Publication of the Protein Society, 27(1), 293–315. https://doi.org/10.1002/pro.3330
   PubMed Web of Science ®Google Scholar
• Wing, K., Yamaguchi, T., & Sakaguchi, S. (2011). Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends in Immunology, 32(9), 428–433. https://doi.org/10.1016/j.it.2011.06.002
   PubMed Web of Science ®Google Scholar
• Wu, Y., Guo, Y., Huang, A., Zheng, P., & Liu, Y. (1997). CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. The Journal of Experimental Medicine, 185(7), 1327–1335. https://doi.org/10.1084/jem.185.7.1327
   PubMed Web of Science ®Google Scholar
• Yin, S., Ding, F., & Dokholyan, N. V. (2007a). Eris: An automated estimator of protein stability. Nature Methods, 4(6), 466–467. https://doi.org/10.1038/nmeth0607-466
   PubMed Web of Science ®Google Scholar
• Yin, S., Ding, F., & Dokholyan, N. V. (2007b). Modeling backbone flexibility improves protein stability estimation. Structure (London, England : 1993), 15(12), 1567–1576. https://doi.org/10.1016/j.str.2007.09.024
   PubMed Web of Science ®Google Scholar
• Yu, C., Sonnen, A. F.-P., George, R., Dessailly, B. H., Stagg, L. J., Evans, E. J., Orengo, C. A., Stuart, D. I., Ladbury, J. E., Ikemizu, S., Gilbert, R., J., C., & Davis, S. J. (2011). Rigid-body ligand recognition drives cytotoxic T-lymphocyte antigen 4 (CTLA-4) receptor triggering. The Journal of Biological Chemistry, 286(8), 6685–6696. https://doi.org/10.1074/jbc.M110.182394
   PubMed Web of Science ®Google Scholar
• Zhang, X., Schwartz, J.-C D., Almo, S. C., & Nathenson, S. G. (2002). Expression, refolding, purification, molecular characterization, crystallization, and preliminary X-ray analysis of the receptor binding domain of human B7-2. Protein Expression and Purification, 25(1), 105–113. https://doi.org/10.1006/prep.2002.1616
   PubMed Web of Science ®Google Scholar